Gestational diabetes & diabetes in pregnancy
Prevalence and treatment of gestational diabetes in Norway 2010–2020
Authors' conclusion
Both the proportion diagnosed with GDM within recommended time of screening, and who received pharmacological treatment, increased substantially following new guidelines in 2017. Prevalence of GDM increased from 2010 to 2016, then plateaued.
Study context
- Population
- Women giving birth in Norway 2010–2020, national registers on births, prescriptions, education, primary and specialist care
- Participants
- 633,169 pregnancies
- Outcome
- Prevalence of GDM and its treatment; impact of new national GDM guidelines in 2017
- Follow-up
- 2010–2020
Methodological detailsregister-based
- Register-based
Main finding
As reported in the abstract
GDM prevalence · 2010 to 2016, then stabilized
Gestational diabetes mellitus (GDM) prevalence in 2010
2.6 %
GDM prevalence in 2016, then stabilized
6.0 %
Observational data: associations, not effects.
Further findings
GDM prevalence by BMI, age, education and maternal birthplace
- Similar patterns across strata; prevalence higher with higher BMI, higher age, lower education, and mothers born in Asia, Africa or Middle East
Proportion of GDM population pharmacologically treated
%
- 2010
- 11.6
- 2016
- 13.6
- 2020
- 31.6
GDM diagnosed in recommended gestational week 24-28
%
- 2010
- 19
- 2020
- 45
Original publication
Prevalence and treatment of gestational diabetes in Norway 2010–2020. Diabetes Res Clin Pract. Published 22 November 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →